Artiva Biotherapeutics (ARTV) Earnings Date, Estimates & Call Transcripts $2.64 -0.23 (-8.01%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$2.70 +0.06 (+2.46%) As of 06:29 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Artiva Biotherapeutics Earnings Summary Artiva Biotherapeutics issued Q2 2025 earnings on August 6, 2025, reporting an EPS of -$0.87, which missed analysts' consensus estimates of -$0.84 by $0.03. With a trailing EPS of $0.00, Artiva Biotherapeutics' earnings are expected to grow next year, from ($4.95) to ($2.83) per share. Latest Q2 Earnings DateAug. 6EstimatedConsensus EPS (Aug. 6) -$0.84 Actual EPS (Aug. 6) -$0.87 Missed By -$0.03 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)Powered by Get Artiva Biotherapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Artiva Biotherapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataARTV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Artiva Biotherapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.68-$0.62-$0.65Q2 20252-$0.71-$0.66-$0.69Q3 20252-$0.74-$0.70-$0.72Q4 20252-$0.76-$0.57-$0.67 FY 2025 8 -$2.89 -$2.55 -$2.72 Q1 20261-$0.73-$0.73-$0.73Q2 20261-$0.76-$0.76-$0.76Q3 20261-$0.78-$0.78-$0.78Q4 20261-$0.81-$0.81-$0.81 Artiva Biotherapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025-$0.84-$0.87 -$0.03-$0.87--5/8/2025--$0.68-$0.83 -$0.15-$0.83--11/12/2024--$0.68-$0.92 -$0.24-$0.92$0.30M-8/29/2024Q2 2024-$1.07-$19.10 -$18.03-$16.20-- Artiva Biotherapeutics Earnings - Frequently Asked Questions When did Artiva Biotherapeutics announce their last quarterly earnings? Artiva Biotherapeutics (NASDAQ:ARTV) last announced its quarterly earning data on Wednesday, August 6, 2025. Learn more on ARTV's earnings history. Did Artiva Biotherapeutics beat their earnings estimates last quarter? In the previous quarter, Artiva Biotherapeutics (NASDAQ:ARTV) missed the analysts' consensus estimate of ($0.84) by $0.03 with a reported earnings per share (EPS) of ($0.87). Learn more on analysts' earnings estimate vs. ARTV's actual earnings. How much revenue does Artiva Biotherapeutics generate each year? Artiva Biotherapeutics (NASDAQ:ARTV) has a recorded annual revenue of $250,000.00. How much profit does Artiva Biotherapeutics generate each year? Artiva Biotherapeutics (NASDAQ:ARTV) has a recorded net income of -$65.37 million. ARTV has generated $0.00 earnings per share over the last four quarters. What is Artiva Biotherapeutics' EPS forecast for next year? Artiva Biotherapeutics' earnings are expected to grow from ($4.95) per share to ($2.83) per share in the next year. More Earnings Resources from MarketBeat Related Companies Monte Rosa Therapeutics Earnings Date Cartesian Therapeutics Earnings Date Foghorn Therapeutics Earnings Date Rocket Pharmaceuticals Earnings Date Inhibrx Biosciences Earnings Date Abeona Therapeutics Earnings Date Atea Pharmaceuticals Earnings Date Altimmune Earnings Date Allogene Therapeutics Earnings Date ADC Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a RallyRivian Takes Earnings Hit—R2 Could Be the Stock's 2026 LifelinePalantir Stock Soars After Blowout Earnings ReportVertical Aerospace's New Deal and Earnings De-Risk Production This page (NASDAQ:ARTV) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artiva Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artiva Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.